Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs

Topics Drugmaker | Pfizer | GSK


Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.

Nearly all of the price increases will be below 10%, and around half of them are in the range of 4 to 6%, said 3 Axis co-founder Eric Pachman. The median price increase is around 5%, he said. More price increases are expected to be announced later this week, which could affect the median.

This article is no longer available in our repository.

There could be multiple reasons for this.